Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
89Zr-immuno-PET using the anti-LAG-3 tracer [89Zr]Zr-BI 754111: demonstrating target specific binding in NSCLC and HNSCC.
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2068-2080. doi: 10.1007/s00259-023-06164-w. Epub 2023 Mar 2.
Eur J Nucl Med Mol Imaging. 2023.
PMID: 36859619
Free PMC article.
Praluzatamab Ravtansine, a CD166-Targeting Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors: An Open-Label Phase I/II Trial.
Boni V, Fidler MJ, Arkenau HT, Spira A, Meric-Bernstam F, Uboha N, Sanborn RE, Sweis RF, LoRusso P, Nagasaka M, Garcia-Corbacho J, Jalal S, Harding JJ, Kim SK, Miedema IHC, Vugts DJ, Huisman MC, Zwezerijnen GJC, van Dongen GAMS, Menke van der Houven van Oordt CW, Wang S, Dang T, Zein IA, Vasiljeva O, Lyman SK, Paton V, Hannah A, Liu JF.
Boni V, et al. Among authors: miedema ihc.
Clin Cancer Res. 2022 May 13;28(10):2020-2029. doi: 10.1158/1078-0432.CCR-21-3656.
Clin Cancer Res. 2022.
PMID: 35165101
Free PMC article.
Clinical Trial.
Item in Clipboard
PET-CT Imaging of Polymeric Nanoparticle Tumor Accumulation in Patients.
Miedema IHC, Zwezerijnen GJC, Huisman MC, Doeleman E, Mathijssen RHJ, Lammers T, Hu Q, van Dongen GAMS, Rijcken CJF, Vugts DJ, Menke-van der Houven van Oordt CW.
Miedema IHC, et al.
Adv Mater. 2022 May;34(21):e2201043. doi: 10.1002/adma.202201043. Epub 2022 Apr 25.
Adv Mater. 2022.
PMID: 35427430
Item in Clipboard
89Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer.
Verhoeff SR, van de Donk PP, Aarntzen EHJG, Oosting SF, Brouwers AH, Miedema IHC, Voortman J, Menke-van der Houven van Oordt WC, Boellaard R, Vriens D, Slingerland M, Hermsen R, Grunsven IVE, Heskamp S, van Herpen CML.
Verhoeff SR, et al. Among authors: miedema ihc.
J Nucl Med. 2022 Oct;63(10):1523-1530. doi: 10.2967/jnumed.121.263470. Epub 2022 May 5.
J Nucl Med. 2022.
PMID: 35512998
Free PMC article.
Item in Clipboard
Design, development and clinical translation of CriPec®-based core-crosslinked polymeric micelles.
Rijcken CJF, De Lorenzi F, Biancacci I, Hanssen RGJM, Thewissen M, Hu Q, Atrafi F, Liskamp RMJ, Mathijssen RHJ, Miedema IHC, Menke-van der Houven van Oordt CW, van Dongen GAMS, Vugts DJ, Timmers M, Hennink WE, Lammers T.
Rijcken CJF, et al. Among authors: miedema ihc.
Adv Drug Deliv Rev. 2022 Dec;191:114613. doi: 10.1016/j.addr.2022.114613. Epub 2022 Nov 4.
Adv Drug Deliv Rev. 2022.
PMID: 36343757
Review.
Item in Clipboard
89Zr-Immuno-PET with Immune Checkpoint Inhibitors: Measuring Target Engagement in Healthy Organs.
Miedema IHC, Wijngaarden JE, Pouw JEE, Zwezerijnen GJC, Sebus HJ, Smit E, de Langen AJ, Bahce I, Thiele A, Vugts DJ, Boellaard R, Huisman MC, Menke-van der Houven van Oordt CW.
Miedema IHC, et al.
Cancers (Basel). 2023 Nov 23;15(23):5546. doi: 10.3390/cancers15235546.
Cancers (Basel). 2023.
PMID: 38067257
Free PMC article.
Item in Clipboard
Localized Peritumoral AL Amyloidosis Associated With Mantle Cell Lymphoma With Plasmacytic Differentiation.
Yabe M, Ozkaya N, de Jong D, Aypar U, Ritorto MS, Barbé E, Miedema IHC, Sen F, Chapman JR, Landau HJ, Dogan A.
Yabe M, et al. Among authors: miedema ihc.
Am J Surg Pathol. 2021 Jul 1;45(7):939-944. doi: 10.1097/PAS.0000000000001684.
Am J Surg Pathol. 2021.
PMID: 33739787
Free PMC article.
Item in Clipboard
Multiparameter Flow Cytometry Assay for Quantification of Immune Cell Subsets, PD-1 Expression Levels and PD-1 Receptor Occupancy by Nivolumab and Pembrolizumab.
Pluim D, Ros W, Miedema IHC, Beijnen JH, Schellens JHM.
Pluim D, et al. Among authors: miedema ihc.
Cytometry A. 2019 Oct;95(10):1053-1065. doi: 10.1002/cyto.a.23873. Epub 2019 Aug 12.
Cytometry A. 2019.
PMID: 31407460
Free article.
Item in Clipboard
Cite
Cite